argenx SE
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
10 aug 2016 - 07:00
Statutaire naam
argenx SE
Titel
argenx to Present at Wedbush PacGrow Healthcare Conference
Bericht
Breda, the Netherlands / Ghent, Belgium - argenx N.V. (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced that Chief Executive Officer, Tim Van Hauwermeiren, will present a corporate update at the Wedbush PacGrow Healthcare Conference in New York City (NY, USA) on Wednesday, August 17, 2016 at 8:35 am ET.
Gerelateerde downloads
Datum laatste update: 22 februari 2026